Company Filing History:
2 out of 2 
1 out of 598 Years Active: 2016-2018
Title: Eun Sook Chung: Innovator in Pharmaceutical Composition
Introduction
Eun Sook Chung is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that utilize bee venom for therapeutic purposes. With a total of 3 patents, his work focuses on addressing diseases related to regulatory T cell activity.
Latest Patents
Eun Sook Chung's latest patents include a pharmaceutical composition comprising bee venom-phospholipase A2 (BV-PLA2) aimed at treating or preventing diseases associated with the degradation of abnormal regulatory T cell activity. This invention highlights a polypeptide that includes a bee venom-PLA2 amino acid sequence, which serves as an active ingredient. The secretory bee venom-phospholipase A2 activates regulatory T cells and suppresses the differentiation of Th1/Th7 cells. Consequently, this polypeptide can be utilized as a pharmaceutical composition for treating or preventing autoimmune diseases, allergic diseases, and neurodegenerative diseases.
Career Highlights
Eun Sook Chung has worked with various organizations, including Inist St Co., Ltd. and the University-industry Cooperation Group of Kyung Hee University. His experience in these institutions has contributed to his expertise in pharmaceutical innovations.
Collaborations
Eun Sook Chung has collaborated with notable colleagues such as Hyun Su Bae and Hyo Jung Lee, who is a woman. These collaborations have further enriched his research and development efforts in the pharmaceutical field.
Conclusion
Eun Sook Chung is a distinguished inventor whose work in pharmaceutical compositions utilizing bee venom has the potential to address significant health challenges. His contributions to the field are noteworthy and continue to influence advancements in medical treatments.